2 completed, 1 enrolling by invitation, 1 terminated. 4 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Completed 2, Enrolling by invitation 1, Terminated 1 |
Follow sham treatment: new trials by email Literature Review of sham treatment trials Research Report on sham treatment
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pre-operative Vabysmo in Patients With Non-clearing Vitreous Hemorrhage Secondary to Proliferative Diabetic Retinopathy Faricimab Injection, sham treatment - Diabetic Retinopathy, Vitreous Hemorrhage Due to Diabetes Mellitus | Phase 4 | Enrolling by invitation | University of Colorado, Denver | 100 | 2024-07-12 | 2026-06-01 |
| The Qure Study: Q-fever Fatigue Syndrome - Response to Treatment Cognitive behavioral therapy, Doxycycline, Placebo - Q Fever, Fatigue Syndrome, Chronic | Phase 4 | Completed | Radboud University Medical Center | 156 | 2011-04-01 | 2021-06-23 |
| Influence of Transcranial Direct Current Stimulation of the Primary Motor Cortex on Pain Sensation in Patients Suffering From Fibromyalgia Syndrome transcranial direct current stimulation, sham treatment - Fibromyalgia | Phase 4 | Terminated | Karl Landsteiner Institute of Remobilization and Functional Health | 50 | 2010-12-01 | 2014-07-03 |
| FS-67 in the Treatment of Pediatric Patients With Ankle Sprain FS-67 Patch, Placebo Patch - Ankle Sprain | Phase 4 | Completed | Hisamitsu Pharmaceutical Co., Inc. | 252 | 2009-12-01 | 2022-10-06 |
Ankle Injuries (1) · Chronic Pain (1) · Diabetic Retinopathy (1) · Fatigue (1) · Fatigue Syndrome, Chronic (1) · Fibromyalgia (1) · Q Fever (1)
Hisamitsu Pharmaceutical Co., Inc. (1) · Karl Landsteiner Institute of Remobilization and Functional Health (1) · Radboud University Medical Center (1) · University of Colorado, Denver (1)
United States (2) · Austria (1) · Netherlands (1)
Chantal P Bleeker-Rovers, MD PhD (1) · Michael Quittan, PhD (1) · Yoshinobu Higashi (1)